Sanofi is following in the footsteps of ... said the pharma group. The range of consumer healthcare products it offers will also be “streamlined” ahead of the spin-off. According to the ...

Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for ... a good fit with its existing business in terms of products and geographies, giving it much increased ...

Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) just unveiled an update. Sanofi Consumer Healthcare India Limited has announced the ...

Jones Financial Companies Lllp raised its stake in Sanofi (NASDAQ:SNY – Free Report) by 55.0% during the 4th quarter, ...

Subject to shareholder approval at the subsequent Annual General Meeting (AGM), the Board of Directors of Sanofi Consumer ...

Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton Dublilier & Rice, known as CD&R. The two companies shared that they have ...

Kuehne+Nagel supports Sanofi in multiple countries worldwide, including Hungary, the UK, and the UAE, by providing customised ...

Sanofi Consumer Healthcare India Limited informed the exchanges that it has approved a final dividend of ₹55 per equity share having a face value of ₹10 each for the financial year ending ...

Sanofi Consumer Heal - Determination Of Book Closure And Record Dates For Dividend Further to our letter dated 20th February, 2025 wherein the Board recommended a final dividend of Rs. 55 per ...

Sanofi Consumer Healthcare India Q4 Results 2025:Sanofi Consumer Healthcare India declared their Q4 results on 20 Feb, 2025. The topline decreased by 20.53% year-over-year (YoY), with profit ...